MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Current Assets of $91.8 million for Q4 2025, down 25.71% on a YoY basis from $123.5 million in Q4 2024, and up 168.51% quarter-over-quarter from $34.2 million in Q3 2025.
MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Current Assets for 9 years, with the latest figure at $91.8 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets fell 25.71% year-over-year to $91.8 million; the trailing twelve-month figure through Dec 2025 stood at $91.8 million (down 25.71% YoY), and the FY2025 full-year result was $91.8 million, down 25.71% from the prior year.
- Current Assets for Q4 2025 stood at $91.8 million, up from $34.2 million in the prior quarter.
- The five-year high for Current Assets was $230.1 million in Q1 2021, with the low at $34.2 million in Q3 2025.
- Historically, Current Assets has averaged $132.9 million across 5 years, with a median of $141.0 million in 2022.
- Annual changes were most pronounced in 2023 — Current Assets jumped 37.1% — and 2025, when it tumbled 75.42%.
- MeiraGTx Holdings' Current Assets stood at $183.2 million in 2021, then fell by 15.77% to $154.3 million in 2022, then increased by 3.42% to $159.6 million in 2023, then retreated by 22.62% to $123.5 million in 2024, then decreased by 25.71% to $91.8 million in 2025.
- The last three Current Assets figures came in at $91.8 million (Q4 2025), $34.2 million (Q3 2025), and $47.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 91.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.76 Mn |
| Sep 30, 2025 | 34.17 Mn |
| Jun 30, 2025 | 47.08 Mn |
| Mar 31, 2025 | 79.89 Mn |
| Dec 31, 2024 | 123.52 Mn |
| Sep 30, 2024 | 139.05 Mn |
| Jun 30, 2024 | 110.77 Mn |
| Mar 31, 2024 | 149.30 Mn |
| Dec 31, 2023 | 159.62 Mn |
| Sep 30, 2023 | 103.53 Mn |
| Jun 30, 2023 | 143.14 Mn |
| Mar 31, 2023 | 121.48 Mn |
| Dec 31, 2022 | 154.34 Mn |
| Sep 30, 2022 | 155.04 Mn |
| Jun 30, 2022 | 104.41 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 183.24 Mn |
| Sep 30, 2021 | 176.93 Mn |
| Jun 30, 2021 | 207.04 Mn |
| Mar 31, 2021 | 230.13 Mn |